AIM ImmunoTech (AIM) Earnings Date & Reports

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AIM is expected to report earnings to fall 10.00% to -9 cents per share on May 15

AIM ImmunoTech AIM Stock Earnings Reports

Q1'25

Est.

$-0.09

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.09

Q1'24

Est.

$-0.12

The last earnings report on March 27 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 6.47K shares outstanding, the current market capitalization sits at 6.88M.

View a ticker or compare two or three

Compare

AIM